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IMPORTANCE Infections are recognized as playing a critical role in the risk of psychiatric
disorders and suicidal behavior; however, few studies have evaluated the risk of eating
disorders.
OBJECTIVE To evaluate the association of hospitalization for infections and treatment with
anti-infective agents with the risk of an eating disorder diagnosis.
DESIGN, SETTING, AND PARTICIPANTS A nationwide, population-based, prospective cohort
study of 525 643 girls born from January 1, 1989, to December 31, 2006, and followed up
until December 31, 2012, was conducted using individual-level data drawn from Danish
longitudinal registers. Data were analyzed from January 15 to June 15, 2018, using survival
analysis models and adjusted for age, calendar period, parental educational level, and
parental history of psychiatric illness.
EXPOSURES Hospital admission for infections and prescribed anti-infective agents for
infections.
MAIN OUTCOMES AND MEASURES The main outcome of interest was diagnosis of an eating
disorder (anorexia nervosa, bulimia nervosa, or eating disorder not otherwise specified) in
a hospital, outpatient clinic, or emergency department setting. Cox proportional hazards
regression models were used to estimate hazard ratios (HRs) and accompanying 95% CIs.
RESULTS The study population consisted of 525 643 adolescent girls: 2131 received a
diagnosis of anorexia nervosa (median [range] age, 15.2 [8.6-21.3] years), 711 received a
diagnosis of bulimia nervosa (median [range] age, 17.9 [13.4-22.7] years), and 1398 received
a diagnosis of an eating disorder not otherwise specified (median [range] age, 15.6 [8.6-21.6]
years). A total of 525 643 adolescent girls were followed up for 4 601 720.4 person-years
until a mean age of 16.2 years (range, 10.5-22.7 years). Severe infections that required
hospitalization were associated with an increased risk of a subsequent diagnosis of anorexia
nervosa by 22% (HR, 1.22; 95% CI, 1.10-1.35), bulimia nervosa by 35% (HR, 1.35; 95% CI,
1.13-1.60), and eating disorder not otherwise specified by 39% (HR, 1.39; 95% CI, 1.23-1.57)
compared with adolescent girls without hospitalizations for infections. Infections treated
with anti-infective agents were associated with an increased risk of a subsequent diagnosis
of anorexia nervosa by 23% (HR, 1.23; 95% CI, 1.10-1.37), bulimia nervosa by 63% (HR, 1.63;
95% CI, 1.32-2.02), and eating disorder not otherwise specified by 45% (HR, 1.45; 95% CI,
1.25-1.67) compared with adolescent girls without infections treated with anti-infective
agents.
CONCLUSIONS AND RELEVANCE The findings suggest that hospital-treated infections and less
severe infections treated with anti-infective agents are associated with increased risk of
subsequent anorexia nervosa, bulimia nervosa, and eating disorders not otherwise specified
and that future studies should investigate whether these associations are causal and identify
the exact mechanisms between infections and subsequent inflammatory processes with
eating disorders.
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I nfections and subsequent inflammatory processes are in-creasingly recognized as playing critical roles in the devel-opment of psychiatric disorders1-7 and suicidal behavior.8,9
However, to our knowledge, only 2 longitudinal studies10,11
have assessed the association between infections and eating
disorders. In both studies,10,11 exposure to infections was as-
sociated with an increased risk of subsequent eating disor-
ders. Because of differences in the exposure period (prenatal
infections10 vs infections during adolescence11), limited ac-
cess to the full range of infections,10,11 and infection severity,
conclusions are limited. Recent evidence of an association be-
tween immune functioning and eating disorders12 has encour-
aged further exploration of the association in large population-
based studies. We therefore conducted a population-based
cohort study to explore the association of infections in child-
hood with risk of subsequent eating disorder diagnosis in ado-
lescent girls only because the incidence rate of adolescent boys
with eating disorders was too low in the Danish population for
these analyses.13
Infections that occur in the population range in severity,
with more severe and rare infections requiring hospital ad-
mission and milder ones being treated with anti-infective
agents in the primary care setting. Regardless of severity, in-
fections may affect the central nervous system through in-
flammatory processes14,15 and/or by triggering autoimmune re-
sponses in vulnerable individuals.16,17 Animal18 and human
disease models19,20 have demonstrated that systemic inflam-
mation can reach the central nervous system, mediating loss
of appetite and taste aversion, which could precipitate eating
disorders in vulnerable individuals. Furthermore, altered in-
flammatory markers have been observed in patients with an-
orexia nervosa (AN)21 and in individuals with obesity with co-
occurring binge-eating disorder.22 Several population-based
studies23-25 have revealed positive associations between eat-
ing disorders and autoimmune diseases, with a recent genome-
wide association study12 further highlighting the probable in-
volvement of immune-related genes in the liability of eating
disorders.
Using a population-based cohort, we evaluated the asso-
ciation of infections with subsequent eating disorder onset. We
specifically explored the extent to which the risk of later eat-
ing disorders differed according to infection severity, with in-
fections that required hospital contacts indicating greater
severity and outpatient anti-infective medication use indicat-
ing milder infections. Our analyses evaluated both dose-
response and temporal associations. To our knowledge, this
was the first population-based register study on all treated in-
fections in the primary and secondary health care sectors to
investigate the subsequent diagnosis of eating disorders.
Methods
Study Population
We conducted a population-based cohort study of the entire
female population born in Denmark from January 1, 1989, to
December 31, 2006, followed up until December 31, 2012, who
were alive and residing in Denmark on their sixth birthday and
registered in the Danish Civil Registration System.26 A per-
sonal identification number is used in all national registers,
enabling linkage among the registers. Data analysis was per-
formed from January 15 to June 15, 2018. All personal infor-
mation from the registers is anonymized when used for re-
search purposes, and the project was approved by the Danish
Data Protection Agency and Statistics Denmark, necessitat-
ing no informed consent.
Registers
The study population was linked to the Danish Psychiatric
Central Research Register,27 which contains data on all
admissions to psychiatric inpatient facilities since 1968.
Information on nationwide somatic hospital contacts is
available from 1977 onward from the Danish National Patient
Register.28 Outpatient information was included from 1995
onward in both registers. Diagnoses were made according to
the International Classification of Diseases, Eighth Revision
(ICD-8)29 (up to 1994) and International Statistical Classifica-
tion of Diseases and Related Health Problems, Tenth Revision
(ICD-10) (from 1995 onward). Treatment in Danish hospitals
is free for all residents, and there are no private psychiatric
inpatient facilities in Denmark, ensuring that all psychiatric
admissions are represented in the registries. The Danish
National Prescription Registry30 contains detailed informa-
tion from all Danish pharmacies on each redeemed prescrip-
tion after January 1, 1995.
Assessment of Exposure
The exposures were hospitalizations attributable to infec-
tions and redeemed prescriptions for anti-infective agents. We
identified hospitalizations for infections since January 1, 1989,
and redeemed prescriptions within the primary care sector for
anti-infective agents since January 1, 1995. eTable 1 and eTable 2
in the Supplement include the hospitalizations for infections
and anti-infective prescriptions evaluated. Because we ex-
pected most individuals to have redeemed prescriptions for
anti-infective agents at some time,31 the reference group was
chosen to be those having 0 to 2 prescriptions. Thus, expo-
sure was defined as the first hospital contact for infections in
the Danish National Patient Register or the date of the third
redeemed prescription.
Key Points
Question Is a prior infection that requires hospitalization or
treatment with an anti-infective agent in childhood associated
with an increased risk of eating disorders in adolescent girls?
Findings In a Danish population-based cohort study of 525 643
adolescent girls, a prior infection in childhood was associated with
an increased risk of later anorexia nervosa, bulimia nervosa, and
eating disorder not otherwise specified.
Meaning The findings suggest that prior exposure to infections
and treatment with anti-infective agents are associated with the
development of eating disorders, supporting an emerging
immunologic hypothesis.
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Assessment of Eating Disorder Outcome
The outcomes of interest were a diagnosis registered in the Dan-
ish Psychiatric Central Research Register or the Danish Na-
tional Patient Register of AN (ICD-10 codes F50.0 and F50.1),
bulimia nervosa (BN) (ICD-10 codes F50.2 and F50.3), and eat-
ing disorder not otherwise specified (EDNOS) (ICD-10 codes
F50.8 and F50.9). Consistent with prior research,32 the eat-
ing disorder diagnoses were not considered to be mutually ex-
clusive (eg, an individual could be diagnosed with AN at one
time point and contribute to the incidence rate of AN and be
diagnosed with BN at a different time point and contribute to
the incidence rate of BN). Onset was defined as the admission
date of the first inpatient, outpatient, or emergency contact




The primary analysis compared individuals who had at least
1 hospital admission for infection with individuals with no hos-
pital admissions and individuals who had 3 or more anti-
infective prescriptions with individuals with 0 to 2 prescrip-
tions on risk of subsequent eating disorder diagnosis. We
estimated hazard ratios (HRs) of AN, BN, and EDNOS sepa-
rately. Infections were registered as time dependent. Thus, in-
dividuals with an eating disorder before the first infection were
counted as being unexposed in the current analyses. We also
investigated possible dose-response associations by evaluat-
ing the number of hospital admissions (0, 1, 2, or ≥3) or num-
ber of prescriptions for an anti-infective agent (0-2, 3-4, 5-9,
or ≥10) and eating disorder risk. We explored temporal asso-
ciations by evaluating the time since the latest hospitaliza-
tion (0-3 months, 3-6 months, 6-12 months, 1-2 years, 2-5 years,
or ≥5 years) and time since the latest prescription for an anti-
infective agent (0-3 months, 3-6 months, 6-12 months, 1-2 years,
2-5 years, or ≥5 years) and eating disorder risk.
The HRs were estimated using Cox proportional hazards
regression models, with age as the underlying timescale. All
analyses were adjusted for age, calendar periods (1995-2000,
2001-2006, and 2007-2012), parental educational level at birth
of the proband, and parental history of any psychiatric illness
since 1969 (ICD-8 codes 290-315 and ICD-10 codes F00-99).
Calendar periods and parental history of psychiatric illness were
treated as time-dependent variables, whereas parental edu-
cational level was considered as time independent. The pro-
portional hazards assumptions were tested based on Schoen-
feld residuals. The Wald test was used to assess linear
associations, and the HRs, 95% CIs, and P values were based
on the Wald statistics. All proportional hazards tests results
were greater than 0.05 (ie, no violation of the proportional haz-
ards assumption). A 2-sided P < .05 based on the χ2 test was
considered to be statistically significant. All analyses were con-
ducted using Stata statistical analysis, version 13 (StataCorp).33
Sensitivity Analysis
Because redeemed prescriptions have been registered since
January 1, 1995, we performed analyses among all girls born
between January 1, 1995, and December 31, 2006, to have a
study population with full information regarding medication
exposure since birth. To best understand the association be-
tween eating disorders and infections, we performed trun-
cated analyses on the risk of eating disorders for the first
12 months from the last hospital admission for infections or a
redeemed anti-infective prescription.
Results
The study population consisted of 525 643 girls born in Den-
mark from January 1, 1989, to December 31, 2006, and fol-
lowed up for 4 601 720.4 person-years until a mean age of 16.2
years (range, 8.6-22.7 years). In this cohort, 2131 received a
diagnosis of AN (median [range] age, 15.2 [10.5-21.3] years), 711
received a diagnosis of BN (median [range] age, 17.9 [13.4-
22.7] years), and 1398 received a diagnosis of EDNOS (median
[range] age, 15.6 [8.6-21.6] years) from January 1, 1995, to
December 31, 2012. The total follow-up time was 4 665 095.1
person-years for AN, 4 671 699.6 person-years for BN, and
4 468 366.5 person-years for EDNOS. Among the adolescent
girls, the incidence rate for AN was 46.0 per 100 000 person-
years, 15.2 per 100 000 person-years for BN, and 38.8 per
100 000 person-years for EDNOS. The incidence of eating
disorders among adolescent boys is reported for descriptive
results only. Among adolescent boys, 193 received a diagno-
sis of AN, 20 received a diagnosis of BN, and 254 received a
diagnosis of EDNOS. The incidence rate among boys with AN
was 4.0 per 100 000 person-years, 0.4 per 100 000 person-
years for BN, and 5.5 per 100 000 person-years for EDNOS.
Table 1 compares hospital stay for infection and number of anti-
infective agents with parental history of psychiatric illness and
parental educational level.
Hospitalization for Infections
History of hospitalization for an infection compared with no
hospitalization was associated with an increased risk of each
eating disorder: 22% increase in AN (HR, 1.22; 95% CI, 1.10-
1.35), 35% increase in BN (HR, 1.35; 95% CI, 1.13-1.60), and 39%
increase in EDNOS (HR, 1.39; 95% CI, 1.23-1.57) (Table 2). The
risk of receiving a diagnosis of AN was associated with the tem-
poral proximity of the last infection (Table 3), with the risks
being highest for an AN diagnosis within the first 3 months af-
ter a hospitalization for an infection (HR, 2.72; 95% CI, 1.20-
5.13; P = .007) (Figure 1), and we found a dose-response asso-
ciation (HR, 1.10; 95% CI, 1.04-1.15; P < .001) (Table 3 and
Figure 2). The risk of receiving a diagnosis of BN after hospi-
talization for an infection was also associated with the tem-
poral proximity since the last infection (Table 3), with the risk
being highest for a diagnosis of BN within the first 3 months
after a hospitalization for an infection (HR, 3.00; 95% CI, 0.96-
6.34; P = .11) (Figure 1). A dose-response association was evi-
dent between hospitalizations and BN (HR, 1.12; 95% CI, 1.03-
1.22; P = .006) (Table 3 and Figure 2). The risk of EDNOS was
also associated with the temporal proximity of the last infec-
tion (Table 3), with the risk being highest for a diagnosis of
EDNOS within the first 3 months after a hospitalization for an
infection (HR, 3.85; 95% CI, 1.72-6.70; P < .001) (Figure 1). The
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results regarding EDNOS fit a dose-response association
(HR, 1.20; 95% CI, 1.13-1.26; P < .001) (Figure 2 and Table 3).
Follow-up analyses with gastrointestinal infections specifi-
cally suggest that the risk of a diagnosis of EDNOS may be great-
est after a hospital stay for a gastrointestinal infection. His-
tory of a hospital stay for a gastrointestinal infection was
associated with a 60% increase in EDNOS (HR, 1.60; 95% CI,
1.26-2.03) (eTable 3 in the Supplement). The rates of other
site-specific (eg, central nervous system) infections in the
current study were too low to provide a valid estimate of risk.
History of hospitalization for an infection compared with no
hospitalization was associated with an increased risk of each
eating disorder after controlling for any previous psychiatric
illness before the first eating disorder diagnosis (eTable 7 in the
Supplement).
Prescription for Anti-infective Agents
Adolescent girls with 3 or more prescriptions for anti-
infective agents had an increased risk of all eating disorders
compared with girls with 2 or fewer prescriptions for anti-
infective agents (Table 2), and temporal (Table 3) and dose-
response associations (Table 3) were present across all eating
disorders. Specifically, infections treated with 3 or more re-
deemed anti-infective agents were associated with a 23% in-
crease in AN (HR, 1.23; 95% CI, 1.10-1.37), 63% increase in BN
(HR, 1.63; 95% CI, 1.32-2.02), and 45% increase in EDNOS (HR,
1.45; 95% CI, 1.25-1.67) (Table 2). The risk of AN (HR, 1.30; 95%
CI, 1.04-1.50; P = .02), BN (HR, 1.43; 95% CI, 1.01-2.04; P = .02),
and EDNOS (HR, 1.64; 95% CI, 1.36-2.28; P < .001) was the high-
est within the first 3 months after the last redeemed prescrip-
tion for an anti-infective agent (Figure 1 and Table 3), and as
the number of redeemed prescriptions increased, the risk of
AN (HR, 1.02; 95% CI, 1.01-1.03; P < .001), BN (HR, 1.04; 95%
CI, 1.02-1.07; P < .001), and EDNOS (HR, 1.04; 95% CI, 1.03-
1.05; P < .001) increased (Figure 2 and Table 3). Adolescent girls
with 3 or more prescriptions for anti-infective agents com-
pared with 2 or fewer had an increased risk of each eating
disorder after controlling for any previous mental disorder
Table 1. Association of Hospital Stay for Infection and Number of Anti-infective Agents
With Parental History of Psychiatric Illness and Parental Educational Level
Risk Factor
No. (%) of Adolescent Girls
Hospitalization for Infections Before 6 y of Age Anti-infective Agents Before 6 y of Age
0 ≥1 ≤2 ≥3













63 009 (14.3) 14 113 (16.9) 31 659 (15.8) 45 463 (14.0)
Secondary
education




688 (0.2) 141 (0.2) 158 (0.1) 671 (0.2)
Length of higher
education
Short 167 761 (37.9) 30 363 (36.4) 75 496 (37.6) 122 628 (37.8)
Medium 142 422 (32.2) 25 281 (30.3) 60 563 (30.1) 107 410 (33.0)
Long 51 236 (11.6) 10 365 (12.4) 24 833 (12.4) 36 768 (11.3)
a Diagnostic crossover between
eating disorders was present.






Eating Disorder Not Otherwise Specified
(n = 1398)
Participants, No. (%) HR (95% CI)a Participants, No. (%) HR (95% CI)a Participants, No. (%) HR (95% CI)a
No hospitalization for
infections
1664 (78.1) 1 [Reference] 533 (75.0) 1 [Reference] 1043 (74.6) 1 [Reference]
Any hospitalization for
infections
467 (21.9) 1.22 (1.10-1.35) 178 (25.0) 1.35 (1.13-1.60) 355 (25.4) 1.39 (1.23-1.57)
≤2 Anti-infective
prescriptions
446 (20.9) 11 [Reference] 107 (15.0) 1 [Reference] 236 (16.9) 1 [Reference]
≥3 Anti-infective
prescriptions
1685 (79.1) 1.23 (1.10-1.37) 604 (85.0) 1.63 (1.32-2.02) 1161 (83.1) 1.45 (1.25-1.67)
Abbreviation: HR, hazard ratio.
a The analyses were adjusted for age, calendar period, parental educational
level, and parental history of psychiatric illness (International Classification of
Diseases, Eighth Revision codes 290-315 and International Statistical
Classification of Diseases and Related Health Problems, Tenth Revision codes
F00-99).
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before the first eating disorder diagnosis (eTable 8 in the
Supplement).
Sensitivity Analyses
Sensitivity analyses were performed among all girls born
between January 1, 1995, and December 31, 2006, yielding a
subpopulation of 368 118 adolescent girls to restrict analyses
to a sample with complete information on hospitalizations
for infections and prescriptions for anti-infective agents
since birth. Of these adolescent girls, 793 received a diagno-
sis of AN, 113 received a diagnosis of BN, and 503 received a
diagnosis of EDNOS. Hospitalizations for infections were
associated with a significant increased risk of BN (HR, 2.00;
95% CI, 1.37-2.92) and EDNOS (HR, 1.44; 95% CI, 1.19-1.75)
(eTable 4 in the Supplement). The risk of EDNOS increased
as the number of hospitalizations increased (eTable 7 and
eTable 8 in the Supplement). Anorexia nervosa, BN, and
EDNOS were associated with the temporal proximity of the
last hospitalization (eTable 6 in the Supplement), with the
risk being highest when the last hospitalization for infec-
tions was within the 3 months before the eating disorder
diagnosis.
Table 3. Risks of Eating Disorders According to Time Since Last Hospital Contact for Infections or Prescriptions for Anti-infective Agents and Number






Eating Disorder Not Otherwise Specified
(n = 1398)
Participants, No. (%) HR (95% CI)a Participants, No. (%) HR (95% CI)a Participants, No. (%) HR (95% CI)a
Infections that required
hospitalization
No hospital contacts 1664 (78.1) 1 [Reference] 533 (75.0) 1 [Reference] 1043 (74.6) 1 [Reference]
Time since last
hospitalizationb
0-3 mo 6 (0.3) 2.72 (1.20-5.13) 4 (0.4) 3.00 (0.96-6.34) 5 (0.4) 3.85 (1.72-6.70)
4-6 mo 8 (0.4) 2.21 (1.10-4.31) 5 (0.7) 2.82 (1.17-5.82) 4 (0.3) 1.14 (0.36-3.54)
7-12 mo 23 (1.1) 2.52 (1.67-2.83) 9 (1.3) 2.01 (1.01-3.81) 13 (0.9) 1.95 (1.13-3.38)
>1 to 2 y 34 (1.6) 1.72 (1.22-2.42) 17 (2.4) 1.76 (1.06-2.92) 32 (2.3) 2.22 (1.56-3.18)
>2 to 5 y 66 (3.1) 1.16 (0.91-1.49) 32 (4.5) 1.28 (0.88-1.84) 56 (4.0) 1.38 (1.06-1.81)
>5 y 330 (15.5) 1.13 (1.00-1.27) 112 (15.8) 1.24 (1.01-1.52) 245 (17.5) 1.29 (1.12-1.49)
Overall P value NA .003 NA .007 NA .01
No. of prescriptions for
anti-infective agents
0-2 446 (20.9) 1 [Reference] 107 (15.0) 1 [Reference] 236 (16.9) 1 [Reference]
Time since last
anti-infective agentb
0-3 mo 107 (5.0) 1.30 (1.04-1.50) 57 (8.0) 1.43 (1.01-2.04) 104 (7.4) 1.64 (1.36-2.28)
4-6 mo 201 (9.4) 1.18 (0.98-1.43) 106 (14.9) 1.39 (1.03-2.01) 150 (10.7) 1.30 (1.03-1.64)
7-12 mo 280 (13.1) 1.25 (1.05-1.49) 121 (17.0) 1.36 (1.02-1.82) 234 (16.7) 1.30 (1.05-1.61)
>1 to 2 y 492 (23.1) 1.11 (0.94-1.29) 191 (26.9) 1.33 (1.01-1.75) 333 (23.8) 1.11 (0.91-1.35)
>2 to 5 y 461 (21.6) 0.96 (0.81-1.13) 92 (12.9) 0.86 (0.56-1.08) 259 (18.5) 0.92 (0.75-1.14)
>5 y 144 (6.8) 0.96 (0.78-1.19) 27 (3.8) 0.55 (0.33-0.75) 82 (5.9) 0.80 (0.60-1.06)
Overall P value NA <.001 NA .01 NA <.001
No. of hospital contacts
for infections
0 1664 (78.1) 1 [Reference] 533 (75.0) 1 [Reference] 1043 (74.6) 1 [Reference]
1 359 (16.9) 1.24 (1.11-1.39) 136 (19.1) 1.36 (1.12-1.64) 252 (18.0) 1.32 (1.14-1.52)
2 73 (3.4) 1.09 (0.86-1.38) 33 (4.6) 1.42 (1.00-2.02) 69 (4.9) 1.52 (1.18-1.94)
≥3 35 (1.6) 1.26 (0.90-1.76) 9 (1.3) 1.00 (0.51-1.93) 34 (2.4) 1.82 (1.29-2.56)
Test for trend P value NA .17 NA .006 NA <.001
No. of prescriptions for
anti-infective agents
0-2 446 (20.9) 1 [Reference] 107 (15.0) 1 [Reference] 236 (16.9) 1 [Reference]
3-4 357 (16.8) 1.17 (1.01-1.34) 129 (18.1) 1.60 (1.12-1.96) 217 (15.5) 1.30 (1.08-1.56)
5-9 618 (29.0) 1.19 (1.05-1.35) 208 (29.3) 1.48 (1.08-1.79) 427 (30.5) 1.46 (1.24-1.71)
≥10 710 (33.3) 1.33 (1.17-1.51) 267 (37.6) 1.83 (1.34-2.21) 518 (37.1) 1.68 (1.43-1.98)
Test for trend P value NA <.001 NA <.001 NA <.001
Abbreviations: HR, hazard ratio; NA, not applicable.
a The analyses were adjusted for age, calendar period, parental educational
level, and parental history of psychiatric illness (International Classification of
Diseases, Eighth Revision codes 290-315 and International Statistical
Classification of Diseases and Related Health Problems, Tenth Revision codes
F00-99).
b Time frames represent amount of time after index hospitalization or
anti-infective treatment.
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No significant increased risks of AN (HR, 1.17; 95% CI, 0.96-
1.44), BN (HR, 1.47; 95% CI, 0.79-2.75), and EDNOS (HR, 1.08;
95% CI, 0.84-1.39) (eTable 4 in the Supplement) were ob-
served in girls with 3 or more prescriptions for anti-infective
agents compared with those with 2 or fewer prescriptions. The
risks of BN and EDNOS were highest in the first 3 months of
redeeming a prescription for anti-infective agents (eTable 7 and
eTable 8 in the Supplement). No dose-response associations
were observed.
To address reverse causality, we performed truncated
analyses for the risk of eating disorders 12 months from the last
hospitalization for an infection or redeemed prescription. The
truncated analyses reduced the total follow-up risk time by ap-
proximately 1.3 million person-years for individuals with pre-
scriptions (range, approximately 3.2 million to 3.3 million per-
son-years) and by approximately 5000 person-years (range,
approximately 4.4 million to 4.6 million person-years) for in-
fections treated in the hospital. Hospitalizations for infec-
tions were associated with a significant increased risk of AN
(HR, 1.20; 95% CI, 1.08-1.33), BN (HR, 1.33; 95% CI, 1.12-1.57),
and EDNOS (HR, 1.40; 95% CI, 1.26-1.56) (eTable 5 in the
Supplement). Adolescent girls with 3 or more prescriptions for
anti-infective agents had a significantly greater risk of AN (HR,
1.19; 95% CI, 1.05-1.34), BN (HR, 1.58; 95% CI, 1.23-2.01), and
EDNOS (HR, 1.34; 95% CI, 1.16-1.55) compared with those with
2 or fewer prescribed anti-infective agents (eTable 5 in the
Supplement).
Discussion
In a population of more than a half million adolescent girls,
more than 4000 of whom were diagnosed with an eating dis-
order, we observed significant associations between infec-
tions in childhood and later eating disorder onset. Infections
that required hospitalization and 3 or more recorded infec-
tions treated with anti-infective agents were associated with
an increased risk of AN, BN, and EDNOS. Furthermore, tem-
poral and dose-response associations were observed. Eating
disorder onset was associated with time since the last hospi-
talization or prescription. The risk of AN, BN, and EDNOS on-
set was greatest in the first 3 months after a hospitalization for
an infection. Similarly, the first 3 months after the last re-
deemed anti-infective agent was the highest-risk period for AN,






























All analyses were adjusted for age, sex, calendar period, parental educational level, and parental history of any psychiatric illness. Error bars indicate 95% CIs.
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otherwise specified
TimeTime
All analyses were adjusted for age, sex, calendar period, parental educational level, and parental history of any psychiatric illness. Error bars indicate 95% CIs.
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BN, and EDNOS onset. Regarding dose response, the risk of AN,
BN, and EDNOS increased as the number of anti-infective
agents increased and the risk of EDNOS increased as the num-
ber of hospitalizations for infections increased. Sensitivity fol-
low-up analyses showed weaker associations between subse-
quent infections compared with prior infections and eating
disorder risk. We continued to observe significant but attenu-
ated risk estimates after controlling for any other psychiatric
illness before the eating disorder diagnosis, suggesting that
comorbidity may play a role. Taken together, our results sug-
gest an association of infections with the pathogenesis of
eating disorders.
To our knowledge, this study was the first nationwide,
prospective study to report an increased risk of AN, BN, and
EDNOS after hospitalizations for infections and was the larg-
est population-based investigation to report an increased
risk of AN, BN, and EDNOS after infections treated with
anti-infective agents. Our results are in line with those of
Raevuori et al,11 who observed an increased use of antimicro-
bial medication in patients with BN and binge-eating disor-
der within the 5 years before eating disorder treatment. Con-
trary to the study by Raevuori et al11 and earlier studies on
the association between infections and AN,34,35 our results
revealed an increased risk for all eating disorder subtypes (AN,
BN, and EDNOS, not just binge-eating subtypes) after use of
anti-infective agents. In addition, we found that the risk of AN,
BN, and EDNOS increased in association with the temporal
proximity of these infections. The observed increased risks of
BN and EDNOS are of similar magnitude with prior epidemio-
logic studies on infections and schizophrenia,2,5,36,37 nonaf-
fective psychosis,38,39 and mood disorders,3-5,37 which also
found dose-response and temporal proximity associations.2,5,36
After controlling for other psychiatric illness before the
eating disorder diagnosis, we continued to observe an in-
creased risk of BN and EDNOS of similar magnitude to those
of schizophrenia,2,5,36,37 nonaffective psychosis,38,39 and mood
disorders3-5,37 in other studies.
The association observed with a broad range of infections
provides support for the emerging immunologic hypothesis
in AN12 and, with previous work,11,24 suggests that the
immune system may also be involved in other eating disorder
subtypes. The sudden onset of AN or food refusal has been
reported in a small number of patients after a variety of infec-
tions, including the neurologic manifestation of acute
rheumatic fever (Sydenham chorea),40,41 streptococcal
infection,42-44 viral meningitis,44 mycoplasma pneumonia,44
coccidiomycosis,45 and influenza.44 Moreover, rapid reduced
and restricted food intake after an infection is a core symptom
of the pediatric acute-onset neuropsychiatric syndrome.46 When
rapid acceleration of symptom onset is preceded by a group A
streptococcal infection, it is referred to as pediatric autoim-
mune neuropsychiatric disorder associated with streptococcal
infection.47 Although the rate of symptom onset or the direc-
tion of effect cannot be inferred from our data, our results
suggest a temporal pattern between infection and the subse-
quent risk of eating disorders.
Prior research has highlighted the complex interplay be-
tween the immune system and eating behaviors,25,48 but only
recently has its role in eating disorder development been in-
vestigated. Infections and inflammation alone can trigger ste-
reotypical behavioral changes, including fever, loss of appe-
tite, decreased food intake, and cellular hypometabolism,49,50
through increased levels of proinflammatory cytokines, such
as tumor necrosis factor and interleukins 1 and 6.51 Infection-
triggered changes in appetite could increase the risk of engag-
ing in disordered eating behaviors in vulnerable individuals.
Furthermore, infections and ingestion of anti-infective agents
can alter the stability of the gut microbiota and, as a result,
could affect mood and behavior via the gut-brain axis.52 Taken
together with the current study results, continuing to ex-
plore the complex interplay among immune responses with
appetite and mood regulation may help explain the associa-
tion of infections and their treatment with the risk of eating
disorders. Without being able to isolate the actual time of eat-
ing disorder symptom onset (vs first presentation to the health
care system), we were unable to discern whether an infection
triggered or accelerated the onset of an eating disorder in a child
with no previous symptoms or, for example, whether sub-
threshold or undetected eating disorder symptoms influ-
enced vulnerability to infection, with a threshold eating dis-
order developing thereafter.
Although our findings suggest that infections are associ-
ated with the subsequent diagnosis of eating disorders, other
mechanisms are possible. Individuals who have a greater li-
ability of developing eating disorders may have an increased
susceptibility to infections for reasons we did not measure
(see limitations below), or a third unmeasured variable, such
as genetic factors, could increase the risk of both infections and
eating disorders. Moreover, Duncan et al12 recently reported,
to our knowledge, the first genome-wide significant locus for
AN in an area related to immune functioning. Taken to-
gether, these findings suggest that individuals who will later
develop an eating disorder might exhibit subtle immunode-
ficiencies associated with increased susceptibility or vulner-
ability to infections. For example, life stressors have been found
to exert immunologic priming on neuroinflammatory pro-
cesses, inducing a vulnerable phenotype characterized in part
by a sensitized neuroimmune microenvironment.53 Thus, prior
stress can lead to a potentiated neuroinflammatory cascade
on exposure to bacterial or viral infection, including changes
in mood and decreased body weight and food intake.54 Be-
cause individuals with eating disorders report high levels of
stress sensitivity and anxiety55-57 and stress alters the neuro-
immune environment, infections may place individuals with
immune deficiencies at greater risk for eating disorders. The
key question remains whether infections are causally in-
volved in the development of eating disorders.
Strengths and Limitations
The population-based design, large sample size, ability to
distinguish eating disorder subtypes, and reliable Danish
registers26-28,30 strengthen our results. However, some limi-
tations within the Danish registers should be noted. The uni-
versal health insurance system in Denmark ensures equal care;
however, community-based studies58,59 suggest that more than
half of eating disorder cases go undetected or undiagnosed.
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The current results include only diagnosed cases of eating dis-
orders. Although no private psychiatric hospitals in Denmark
exist and the nationwide registration of mental disorders is al-
most complete, approximately 20% of patients are treated by
private psychologists and psychiatrists in Denmark.27 These
individuals may not be captured in the Danish Psychiatric Cen-
tral Research Register in the present study. We had no infor-
mation on the use of anti-infective agents during hospital stays
or on medication use before January 1, 1995. Our results are
strengthened by sensitivity analyses on individuals with life-
time medication use data. We only included individuals born
after 1989; however, based on the lifetime incidence of men-
tal disorders,60 we would expect to capture more than half of
individuals diagnosed with an eating disorder. Thus, the co-
hort represents a relevant population concerning the risk of
eating disorders.
The study has some limitations. The current study does
not enable a causal interpretation. The observed associations
could simply be a secondary symptom that occurs alongside
eating disorders instead of reflecting causality. Some parents
may be particularly attentive to somatic and psychiatric symp-
toms, resulting in frequent evaluations by health care profes-
sionals and, thus, a higher likelihood of a diagnosis of an in-
fection or eating disorder. Anti-infective agents are probably
prescribed because of signs of infection61,62; however, signs
of infection in adolescents are largely based on parental re-
port (eg, earache, pain). Thus, anxious parents would be more
likely to take their children to a health care professional and
report signs of an infection, resulting in an increase in treat-
ment of infection and opportunity for a diagnosis of an eating
disorder. Although the risk for an eating disorder after an in-
fection may represent an epiphenomenon, residual confound-
ing may also be present. Frequent antibiotic use may be a proxy
for familial factors because several family factors also corre-
late with more frequent antibiotic use in children, including
lack of emotional support, low parental educational level, and
low socioeconomic status.63-66 Also, we cannot confirm that
individuals actually took the anti-infective medications that
they were prescribed and redeemed. Adherence to anti-
infective treatments is estimated to be approximately 62.2%.61
Antibiotics are prescribed when signs of an infection are pres-
ent; however, overprescription of antibiotics has been re-
ported to be as high as 46%.62 The results of our truncated and
temporal analyses do not rule out the possibility of a bidirec-
tional association between eating disorders and infections, such
that the risk an infection increases after an eating disorder di-
agnosis. Because of the significant somatic morbidity associ-
ated with eating disorders, we are not able to confidently in-
terpret the bidirectionality of the associations. To translate
these findings from epidemiologic associations to underly-
ing mechanisms and clinical prevention or treatment regi-
mens, follow-up work is required.
Conclusions
The findings suggest that infections that require hospitaliza-
tion and treatment with anti-infective agents in childhood
are associated with an increased risk of AN, BN, and EDNOS.
Future studies that can establish more explicit links between
infections and eating disorders may aid in the diagnosis and
treatment of eating disorders.
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